294 related articles for article (PubMed ID: 10779328)
1. Regulation of the Jak2 tyrosine kinase by its pseudokinase domain.
Saharinen P; Takaluoma K; Silvennoinen O
Mol Cell Biol; 2000 May; 20(10):3387-95. PubMed ID: 10779328
[TBL] [Abstract][Full Text] [Related]
2. The pseudokinase domain is required for suppression of basal activity of Jak2 and Jak3 tyrosine kinases and for cytokine-inducible activation of signal transduction.
Saharinen P; Silvennoinen O
J Biol Chem; 2002 Dec; 277(49):47954-63. PubMed ID: 12351625
[TBL] [Abstract][Full Text] [Related]
3. Jak2-Stat5 interactions analyzed in yeast.
Barahmand-Pour F; Meinke A; Groner B; Decker T
J Biol Chem; 1998 May; 273(20):12567-75. PubMed ID: 9575217
[TBL] [Abstract][Full Text] [Related]
4. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
[TBL] [Abstract][Full Text] [Related]
5. Platelet-derived growth factor (PDGF)-induced activation of signal transducer and activator of transcription (Stat) 5 is mediated by PDGF beta-receptor and is not dependent on c-src, fyn, jak1 or jak2 kinases.
Paukku K; Valgeirsdóttir S; Saharinen P; Bergman M; Heldin CH; Silvennoinen O
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):759-66. PubMed ID: 10642538
[TBL] [Abstract][Full Text] [Related]
6. A JAK1/JAK2 chimera can sustain alpha and gamma interferon responses.
Kohlhuber F; Rogers NC; Watling D; Feng J; Guschin D; Briscoe J; Witthuhn BA; Kotenko SV; Pestka S; Stark GR; Ihle JN; Kerr IM
Mol Cell Biol; 1997 Feb; 17(2):695-706. PubMed ID: 9001223
[TBL] [Abstract][Full Text] [Related]
7. An epidermal growth factor receptor/Jak2 tyrosine kinase domain chimera induces tyrosine phosphorylation of Stat5 and transduces a growth signal in hematopoietic cells.
Nakamura N; Chin H; Miyasaka N; Miura O
J Biol Chem; 1996 Aug; 271(32):19483-8. PubMed ID: 8702638
[TBL] [Abstract][Full Text] [Related]
8. Identification of SH2-bbeta as a potent cytoplasmic activator of the tyrosine kinase Janus kinase 2.
Rui L; Carter-Su C
Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7172-7. PubMed ID: 10377387
[TBL] [Abstract][Full Text] [Related]
9. Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway.
Chin H; Arai A; Wakao H; Kamiyama R; Miyasaka N; Miura O
Blood; 1998 May; 91(10):3734-45. PubMed ID: 9573010
[TBL] [Abstract][Full Text] [Related]
10. An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT.
Fujitani Y; Hibi M; Fukada T; Takahashi-Tezuka M; Yoshida H; Yamaguchi T; Sugiyama K; Yamanaka Y; Nakajima K; Hirano T
Oncogene; 1997 Feb; 14(7):751-61. PubMed ID: 9047382
[TBL] [Abstract][Full Text] [Related]
11. Activation of Jak2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop.
Feng J; Witthuhn BA; Matsuda T; Kohlhuber F; Kerr IM; Ihle JN
Mol Cell Biol; 1997 May; 17(5):2497-501. PubMed ID: 9111318
[TBL] [Abstract][Full Text] [Related]
12. Prolactin signal transduction to milk protein genes: carboxy-terminal part of the prolactin receptor and its tyrosine phosphorylation are not obligatory for JAK2 and STAT5 activation.
Goupille O; Daniel N; Bignon C; Jolivet G; Djiane J
Mol Cell Endocrinol; 1997 Mar; 127(2):155-69. PubMed ID: 9099911
[TBL] [Abstract][Full Text] [Related]
13. Differential binding to and regulation of JAK2 by the SH2 domain and N-terminal region of SH2-bbeta.
Rui L; Gunter DR; Herrington J; Carter-Su C
Mol Cell Biol; 2000 May; 20(9):3168-77. PubMed ID: 10757801
[TBL] [Abstract][Full Text] [Related]
14. Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C.
Fernández L; Flores-Morales A; Lahuna O; Sliva D; Norstedt G; Haldosén LA; Mode A; Gustafsson JA
Endocrinology; 1998 Apr; 139(4):1815-24. PubMed ID: 9528967
[TBL] [Abstract][Full Text] [Related]
15. A new protein containing an SH2 domain that inhibits JAK kinases.
Endo TA; Masuhara M; Yokouchi M; Suzuki R; Sakamoto H; Mitsui K; Matsumoto A; Tanimura S; Ohtsubo M; Misawa H; Miyazaki T; Leonor N; Taniguchi T; Fujita T; Kanakura Y; Komiya S; Yoshimura A
Nature; 1997 Jun; 387(6636):921-4. PubMed ID: 9202126
[TBL] [Abstract][Full Text] [Related]
16. APS, an adaptor protein containing Pleckstrin homology (PH) and Src homology-2 (SH2) domains inhibits the JAK-STAT pathway in collaboration with c-Cbl.
Wakioka T; Sasaki A; Mitsui K; Yokouchi M; Inoue A; Komiya S; Yoshimura A
Leukemia; 1999 May; 13(5):760-7. PubMed ID: 10374881
[TBL] [Abstract][Full Text] [Related]
17. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
Tong W; Zhang J; Lodish HF
Blood; 2005 Jun; 105(12):4604-12. PubMed ID: 15705783
[TBL] [Abstract][Full Text] [Related]
18. Mapping of a cytoplasmic domain of the human growth hormone receptor that regulates rates of inactivation of Jak2 and Stat proteins.
Hackett RH; Wang YD; Sweitzer S; Feldman G; Wood WI; Larner AC
J Biol Chem; 1997 Apr; 272(17):11128-32. PubMed ID: 9111009
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase.
Yi W; Kim SO; Jiang J; Park SH; Kraft AS; Waxman DJ; Frank SJ
Mol Endocrinol; 1996 Nov; 10(11):1425-43. PubMed ID: 8923468
[TBL] [Abstract][Full Text] [Related]
20. Jak1 plays an essential role for receptor phosphorylation and Stat activation in response to granulocyte colony-stimulating factor.
Shimoda K; Feng J; Murakami H; Nagata S; Watling D; Rogers NC; Stark GR; Kerr IM; Ihle JN
Blood; 1997 Jul; 90(2):597-604. PubMed ID: 9226159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
